TREVENA INC 4
4 · TREVENA INC · Filed Dec 11, 2015
Insider Transaction Report
Form 4
TREVENA INCTRVN
Soergel David
Sr. VP, Clinical Development
Transactions
- Sale
Common Stock
2015-12-10$10.55/sh−27,217$287,139→ 1,750 total
Footnotes (2)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 23, 2015.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in several transactions at prices ranging from $10.13 - $10.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.